SAVOREAT LTD.
INTERIM FINANCIAL INFORMATION
(Unaudited)
AS OF JUNE 30, 2023
SAVOREAT LTD.
INTERIM FINANCIAL INFORMATION
(Unaudited)
AS OF JUNE 30, 2023
TABLE OF CONTENTS | |
Page | |
AUDITORS' REVIEW REPORT | 2 |
CONDENSED CONSOLIDATED INTERIM FINANCIAL INFORMATION - IN | |
NEW ISRAELI SHEKELS (NIS): | |
Condensed consolidated statement of financial position | 3 |
Condensed consolidated statement of comprehensive income | 4 |
Condensed consolidated statement of changes in equity | 5 |
Condensed consolidated statement of cash flows | 6 |
Notes to the condensed consolidated financial information | 7-14 |
The accompanying audit report is a non-binding translation into English of the original audit
report published in Hebrew. The version in Hebrew is the approved text.
Introduction
We have reviewed the attached financial information of SavorEat Ltd. (hereinafter - the Company), which is comprised of the condensed statement of financial position as of June 30, 2023 and the condensed statements of comprehensive income, changes in equity and cash flows for the six-month period ended on that date. The Board of Directors and management are responsible for the preparation and presentation of the financial information for this interim period in accordance with the provisions of IAS 34 "Interim Financial Reporting" and are responsible for presentation of the financial information for this interim period in accordance with Chapter D to the Securities Regulations (Periodic and Immediate Reports), 1970. Our responsibility is to express a conclusion with respect to the financial information for this interim period, based on our review.
Scope of review
Our review was conducted in accordance with the provisions of Review Standard (Israel) 2410 of the Institute of Certified Public Accountants in Israel concerning 'Review of financial information for interim periods undertaken by the entity's auditor.' A review of financial information for interim periods consists of making enquiries, in particular, of those officials responsible for financial and accounting matters, and of the application of analytical and other review procedures. A review is substantially lesser in scope than an audit conducted in accordance with auditing standards generally accepted in Israel and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion.
Conclusion
Based on our review, nothing has come to our attention that causes us to believe that the above financial information is not prepared, in all material respects, in accordance with IAS 34.
Further to the preceding paragraph, based on our review, nothing has come to our attention that causes us to believe that the above financial information is not in compliance, in all material respects, with the disclosure provisions in Chapter D of Israel Security Regulations (Periodic and Immediate Reports), 1970.
Without qualifying our conclusion above, we draw attention to note 1g to the financial statements which describes that the Company is in research and development stages, and therefore, has not yet generated revenue, has accumulated losses and negative cash flows in light of development and ongoing activity since its date of incorporation and will require additional financing resources to continue its activity, the obtaining of which is uncertain. Those factors cast significant doubt on the Company's ability to continue as a going concern. Management plans in relation to those matters are presented in note 1g. These financial statements do not include any adjustments relating to the values and classification of asset and liabilities that might be necessary should the Company be unable to continue as a going concern.
Tel-Aviv, Israel | Kesselman & Kesselman |
August 17, 2023 | Certified Public Accountants (lsr.) |
A member firm of PricewaterhouseCoopers International Limited |
Kesselman & Kesselman, 146 Derech Menachem Begin St. Tel-Aviv 6492103, Israel,
P.O Box 7187 Tel-Aviv 6107120, Telephone: +972 -3- 7954555, Fax:+972 -3- 7954556, www.pwc.com/il
SAVOREAT LTD.
CONDENSED CONSOLIDATED STATEMENT OF FINANCIAL POSITION
AS OF JUNE 30, 2023 | ||||||
As of June 30 | As of | |||||
December 31, | ||||||
2023 | 2022 | 2022 | ||||
(Unaudited) | (Audited) | |||||
NIS in thousands | ||||||
A s s e t s | ||||||
CURRENT ASSETS: | ||||||
Cash and cash equivalents | 19,062 | 20,023 | 28,538 | |||
Short-term deposits | 6,597 | 15,004 | - | |||
Other receivables | 1,277 | 2,731 | 3,188 | |||
26,936 | 37,758 | 31,726 | ||||
NON-CURRENT ASSETS: | ||||||
Property, plant and equipment, net | 639 | 680 | 711 | |||
Right-of-use asset | 192 | 307 | 139 | |||
Investment in associate accounted for using the | ||||||
equity method | - | 974 | 544 | |||
Restricted deposits | 173 | 91 | 139 | |||
Total assets | 27,940 | 39,810 | 33,259 | |||
Liabilities and equity | ||||||
CURRENT LIABILITIES: | ||||||
Accounts payable | 803 | 1,009 | 1,047 | |||
Trade payables | 591 | 813 | 405 | |||
Current maturities on lease | 237 | 368 | 177 | |||
1,631 | 2,190 | 1,629 | ||||
NON-CURRENT LIABILITIES: | ||||||
Liability for options | - | 315 | - | |||
Total liabilities | 1,631 | 2,505 | 1,629 | |||
EQUITY: | ||||||
Ordinary share capital | 22 | 21 | 22 | |||
Share premium | 64,665 | 59,859 | 64,665 | |||
Capital reserve | 5,381 | 5,607 | 5,725 | |||
Accumulated loss | )43,759( | )28,182( | (38,782) | |||
Total equity | 26,309 | 37,305 | 31,630 | |||
Total liabilities and equity | 27,940 | 39,810 | 33,259 |
Date of approval of the financial information: August 17, 2023.
Oded Shoseyov | Racheli Vizman | Mira Damgian | ||
Chairman of | Chief Executive | Chief Financial | ||
the Board | Officer | Officer |
The accompanying notes are an integral part of this condensed financial information.
3
SAVOREAT LTD.
CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME
FOR THE SIX-MONTH PERIOD ENDED JUNE 30, 2023
Six months ended | Year ended | ||||
June 30 | December 31 | ||||
2023 | 2022 | 2022 | |||
(Unaudited) | (Audited) | ||||
NIS in thousands | |||||
Research and development expenses, net | )4,405( | )5,658( | (12,574) | ||
Administrative and general expense | )945( | )1,906( | (4,272) | ||
Marketing expenses | )98( | )858( | (1,909) | ||
Operating loss | )5,448( | )8,422( | (18,755) | ||
Changes in fair value of derivative | |||||
financial instruments | 4,129 | 3,934 | |||
Finance income | 1,027 | 1,144 | 1,512 | ||
Finance expenses | )12( | )68( | (78) | ||
Decrease in ownership interest, and share | |||||
in losses of associate accounted for | )544( | 124 | (306) | ||
using the equity method | |||||
Loss and comprehensive loss | )4,977( | )3,093( | (13,693) | ||
(Loss) per share | |||||
Basic (loss) per share | )2.27( | )1.49( | (6.42) | ||
Diluted (loss) per share | )2.27( | )3.39( | (8.17) |
The accompanying notes are an integral part of this condensed financial information.
4
Attention: This is an excerpt of the original content. To continue reading it, access the original document here. |
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Savoreat Ltd. published this content on 28 August 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 28 August 2023 14:47:03 UTC.